AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Ever since the anti-inflammatory drugs, Celebrex and Vioxx, came on the market two and a half years ago, questions have surrounded them. Do these costly drugs offer a safer alternative to other arthritis drugs? Do they have a lower rate of the gastrointestinal side effects associated with older painkillers, such as aspirin, ibuprofen, and acetaminophen? If so, is this benefit canceled by heart-related risks linked to Celebrex and Vioxx?
A new analysis of all clinical trials that had attempted to answer these questions was conducted by Debabrata Mukherjee, MD, and colleagues at the Cleveland Clinic Foundation. But before their analysis appeared in the Journal of the American Medical…
Source: HighBeam Research, CELEBREX AND VIOXX: ARE THEY SAFER THAN THE OLDER ANTI- INFLAMMATORY...